← Back to Search

Intraocular Lens

Treatment Group 1 for Cataract

N/A
Waitlist Available
Led By Steven J Dell, MD
Research Sponsored by Dell Laser Consultants
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days post-operative
Awards & highlights
No Placebo-Only Group

Summary

The objective of this study is to evaluate the uncorrected binocular distance, intermediate, and near visual acuities, and assess patient's spectacle independence and satisfaction in individuals undergoing bilateral cataract extraction that have received two different arms of near add design IOLs of the same diffractive multifocal model.

Eligible Conditions
  • Cataract

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days post-operative
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days post-operative for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Measurements of uncorrected and best corrected visual acuities under mesopic illumination at distance, intermediate, and near using the ETDRS chart.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Treatment Group 1Active Control1 Intervention
50 qualified study patients will receive the +2.75D (ZKB00) in their dominant eye and the +3.25D (ZLB00) in their non-dominant eye.
Group II: Treatment Group 2Active Control1 Intervention
50 qualified study patients will receive the +2.75D (ZKB00) in their dominant eye and the +4.00D (ZMB00) in their non-dominant eye.

Find a Location

Who is running the clinical trial?

Dell Laser ConsultantsLead Sponsor
Abbott Medical OpticsIndustry Sponsor
44 Previous Clinical Trials
6,693 Total Patients Enrolled
23 Trials studying Cataract
4,567 Patients Enrolled for Cataract
Steven J Dell, MDPrincipal InvestigatorDell Laser Consultants
1 Previous Clinical Trials
88 Total Patients Enrolled
~10 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top